Table 9. Postoperative morbidity in HIPEC and control groups.
| Type of complications | Grade CTCAE v. 4.03 | N (%) |
|---|---|---|
| HIPEC group | ||
| Non-surgical complications | ||
| Enterocolitis | I | 1 (5.0) |
| Fever of unclear genesis | I | 2 (10.0) |
| Pneumonia | II | 5 (25.0) |
| Pleural effusion | II | 1 (5.0) |
| Thrombophlebitis of subcutaneous veins | II | 1 (5.0) |
| Acute kidney failure | II | 1 (5.0) |
| Surgical complications | ||
| Postoperative pancreatitis | II | 4 (20.0) |
| Pancreatic fistula | II | 1 (5.0) |
| Volvulus of ileal loops, serosal peritonitis | IV | 1 (5.0) |
| Mesothrombosis | V | 1 (5.0) |
| Esophagojejunal anastomotic leak | V | 2 (10.0) |
| Total | 20 | |
| Control group | ||
| Non-surgical complications | ||
| Pneumonia | II | 4 (33.3) |
| Myocardial infarction | II | 1 (8.3) |
| Acute ischemic stroke | V | 1 (8.3) |
| Acute gastroenteritis of allergic origin | II | 1 (8.3) |
| Surgical complications | ||
| Wound infection | II | 2 (16.7) |
| Postoperative pancreatitis | II | 2 (16.7) |
| Left liver lobe necrosis, paralytic intestinal obstruction | IV | 1 (8.3) |
| Total | 12 | |
HIPEC, hyperthermic intraperitoneal chemotherapy.